NCCN Guidelines Updates: Management of Prostate Cancer

James L. Mohler; Emmanuel S. Antonarakis

doi:10.6004/jnccn.2019.5011

NCCN Guidelines Updates: Management of Prostate Cancer

James L. Mohler
, Emmanuel S. Antonarakis

Department of Urology

Research output: Contribution to journal › Letter › peer-review

127 Scopus citations

Abstract

Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.

Original language	English
Pages (from-to)	583-586
Number of pages	4
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	55
DOIs	https://doi.org/10.6004/jnccn.2019.5011
State	Published - May 1 2019

Access to Document

10.6004/jnccn.2019.5011

Cite this

@article{f71d92260d7d441688b7f1a20b2f1ec9,

title = "NCCN Guidelines Updates: Management of Prostate Cancer",

abstract = "Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.",

author = "Mohler, \{James L.\} and Antonarakis, \{Emmanuel S.\}",

year = "2019",

month = may,

day = "1",

doi = "10.6004/jnccn.2019.5011",

language = "English",

volume = "17",

pages = "583--586",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "55",

}

TY - JOUR

T1 - NCCN Guidelines Updates

T2 - Management of Prostate Cancer

AU - Mohler, James L.

AU - Antonarakis, Emmanuel S.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.

AB - Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.

UR - https://www.scopus.com/pages/publications/85066486130

U2 - 10.6004/jnccn.2019.5011

DO - 10.6004/jnccn.2019.5011

M3 - Letter

C2 - 31117038

AN - SCOPUS:85066486130

SN - 1540-1405

VL - 17

SP - 583

EP - 586

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 55

ER -

NCCN Guidelines Updates: Management of Prostate Cancer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this